CA

Guy Boivin

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Guy Boivin

Introduction

Guy Boivin is a notable inventor based in Quebec, Canada. He has made significant contributions to the field of medical research, particularly in the development of treatments for microbial infections. With a total of four patents to his name, Boivin's work has the potential to impact public health positively.

Latest Patents

Among his latest patents is a formulation of diltiazem for use in the treatment of microbial infections. This invention relates to diltiazem as an agent for activating the expression of at least one gene encoding a type III interferon, aimed at preventing and/or treating infections caused by pathogenic microorganisms in the respiratory and intestinal tracts. Another significant patent involves an attenuated virus strain derived from a human metapneumovirus strain. This invention includes genetic modifications that attenuate the virulence of the strain, making it a potential candidate for vaccine development.

Career Highlights

Throughout his career, Guy Boivin has worked with prestigious institutions such as Université Laval and Université Claude Bernard Lyon 1. His research has focused on virology and infectious diseases, contributing to advancements in medical science.

Collaborations

Boivin has collaborated with esteemed colleagues, including Manuel Rosa-Calatrava and Olivier Terrier. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.

Conclusion

Guy Bo

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…